<DOC>
	<DOCNO>NCT00365586</DOCNO>
	<brief_summary>The purpose study evaluate effect ketoprofen topical patch pain associate Osteoarthritis Flare Knee .</brief_summary>
	<brief_title>Ketoprofen Topical Patch , 20 % Treatment Pain Associated With Osteoarthritis Flare Knee</brief_title>
	<detailed_description>This randomize , double-blind placebo-controlled parallel group study conduct patient experienced flare osteoarthritis knee . At screening , patient whose pain currently control analgesic agree , give Informed Consent , discontinue analgesic . Eligible patient randomize ( 1:1 ratio ) receive double-blind treatment either ketoprofen topical patch match placebo patch apply daily 28 day . Patients return clinic Days 7 , 14 , 21 28 . At Day 28 , patient may choose open 2 month open-label period . Patients rate pain use Knee Injury Osteoarthritis Outcome Score ( KOOS ) contain WOMAC pain subscale . Patients also complete electronic diary pain intensity , pain relief , quality sleep rating capture . In addition , rescue medication consumption data collect . Ibuprofen provide prn rescue medication .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Males females 18 year age old Diagnosis osteoarthritis knee ( unilateral bilateral ) Meet pain entry criterion Willing discontinue use analgesic medication ( include overthecounter [ OTC ] analgesic ) except provide study treatment rescue medication specifically study purpose . Positive urine pregnancy test , pregnant lactating . Have fibromyalgia , inflammatory arthritis , gout , pseudogout Paget 's disease Have type clinically significant joint disease joint replacement surgery index knee Have receive either corticosteroid injection 4 week precede screen visit hyaluronic acid within 6 month screen visit Have history physical examination find incompatible safe participation study study product use Are take medication substance contraindicate due nature study medication potential drug interaction . Have significant renal hepatic impairment Are take sleep medication dose stable least 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Pain</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>NSAID</keyword>
</DOC>